BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cerus Corporation 

2411 Stanwell Drive

Concord  California  94520   U.S.A.
Phone: 925-288-6000 Fax: 925-288-6001


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device


Collaborations

MedImmune 





 Company News
Cerus Corporation (CERS) To Release First Quarter 2015 Results On May 5, 2015 4/22/2015 8:36:21 AM
First Patient Enrolled In Cerus Corporation (CERS)' TRUE Study With The American Red Cross To Address Chikungunya And Dengue Blood Safety Risks With Pathogen Reduced Platelets 3/16/2015 9:48:44 AM
Cerus Corporation (CERS) Reports Fourth Quarter And Year-End 2014 Results 2/27/2015 10:48:28 AM
Cerus Corporation (CERS) Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier 2/27/2015 8:24:57 AM
Cerus Corporation (CERS) To Present At The Cowen and Company 35th Annual Health Care Conference On March 3, 2015 2/24/2015 11:09:37 AM
Cerus Corporation (CERS) To Release Fourth Quarter 2014 Results On February 26, 2015 2/13/2015 10:06:12 AM
Cerus Corporation (CERS) And SunCoast Blood Bank Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/5/2015 10:46:02 AM
Cerus Corporation (CERS) And Blood Bank Of Delmarva Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/4/2015 11:00:50 AM
Ash Stevens To Manufacture Amotosalen Active Pharmaceutical Ingredient For Cerus Corporation (CERS)' INTERCEPT Blood System 1/28/2015 8:08:16 AM
Cerus Corporation (CERS) Prices $70.0 Million Public Offering Of Common Stock 1/7/2015 11:08:44 AM
12345678910...